Omslagsbillede

Evaluation of Adverse Drug Events of Remdesivir for the Treatment of COVID-19 in Patients Contacting the 13-Aban Pharmacy Drug and Poison Information Center

Background: One of the FDA-approved treatments for COVID-19 is remdesivir. In this study, we investigated adverse drug events (ADEs) of remdesivir in COVID-19 patients who contacted 13-Aban pharmacy's drug and poison information center (DPIC). Methods: In this study, data of patients receiving...

Fuld beskrivelse

Saved in:

Bibliografiske detaljer
Main Authors:	Amirhosein Ghahremanian (Author), Hasti Photography (Author), Sona Ghasemi (Author), Mohammadreza Heidari (Author), Elliyeh ghadrdan (Author)
Format:	Bog
Udgivet:	Research Center for Rational Use of Drugs (RCRUD), 2023-09-01T00:00:00Z.
Fag:	article
Online adgang:	Connect to this object online.
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Lignende værker

El canvi climàtic : canviar els valors abans que no sigui massa tard
af: Jordi Miralles
Udgivet: (2007)

Simulation of Remdesivir Pharmacokinetics and Its Drug Interactions
af: Subrata Deb, et al.
Udgivet: (2021)

What Do We Know About Remdesivir Drug Interactions?
af: Katherine Yang
Udgivet: (2020)

ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential
af: Subrata Deb, et al.
Udgivet: (2021)

Interaction of Remdesivir with Clinically Relevant Hepatic Drug Uptake Transporters
af: Anne T. Nies, et al.
Udgivet: (2021)

Assessment of Knowledge, Attitude, and Practice in the General Population Regarding Hypertension: A Cross-Sectional Study from Iran
af: Fariba Lookian, et al.
Udgivet: (2019)

Hyperprolactinemia and Galactorrhea Associated with Risperidone-Fluoxetine Combination Therapy: A Case Report
af: Nastaran Kordjazy, et al.
Udgivet: (2020)

Postmarketing pharmacovigilance: Remdesivir and cardiovascular events
af: John T. Sullivan
Udgivet: (2022)

Contact dermatitis syndrome to poison ivy
af: Marina Seki, et al.
Udgivet: (2023)

Poisoning by anti-malarial drugs
af: David Tibbutt
Udgivet: (2013)

Integration Analysis of Pharmacokinetics and Metabolomics to Predict Metabolic Phenotype and Drug Exposure of Remdesivir
af: Ping Du, et al.
Udgivet: (2022)

Childhood Drug and Non-Drug Poisoning in Nigeria: An Economic Appraisal
af: Ifunanya Ikhile, et al.
Udgivet: (2019)

Study of Potential Drug-Drug Interactions in Prescriptions of University- Based Pharmacies
af: Sarah Mousavi, et al.
Udgivet: (2015)

Molecular docking assisted exploration on solubilization of poorly soluble drug remdesivir in sulfobutyl ether-tycyclodextrin
af: Yumeng Zhang, et al.
Udgivet: (2022)

Assessment of Pharmacists' Confidence When Consulting Patients on Anticoagulants: A Cross-Sectional Study in Iran
af: Elliyeh Ghadrdan, et al.
Udgivet: (2022)

Designer drug poisonings as a growing clinical problem
af: Barbara Zofia Klatka, et al.
Udgivet: (2019)

Designer drug poisonings as a growing clinical problem
af: Barbara Zofia Klatka, et al.
Udgivet: (2019)

Quenching thirst with poison? Paradoxical effect of anticancer drugs
af: Kaiyuan Chai, et al.
Udgivet: (2023)

Utility of renal replacement therapy in poisoning and drug overdosage
af: Rohit Bhowmick, et al.
Udgivet: (2024)

Metabolic acidosis in multi drug poisoning with antidepressants and antipsychotics
af: Nastaran Eizadi-Mood, et al.
Udgivet: (2021)

Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment
af: Jiashu Xie, et al.
Udgivet: (2021)

Drugs involved in Kentucky drug poisoning deaths and relation with antecedent controlled substance prescription dispensing
af: Patricia R. Freeman, et al.
Udgivet: (2023)

Prevalence of drug poisoning in the state of Bahia between 2007 and 2017
af: Weslley Pedreira Araujo, et al.
Udgivet: (2021)

Pediatric thioridazine poisoning as a result of pharmacy compounding error
af: Zenichiro Kato, et al.
Udgivet: (2009)

Ocular Drug Delivery into the Eyes Using Drug-Releasing Soft Contact Lens
af: Toshihiko Tashima
Udgivet: (2024)

Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System
af: Concetta Rafaniello, et al.
Udgivet: (2021)

Remdesivir and the Liver: A Concise Narrative Review of Remdesivir-Associated Hepatotoxicity in Patients Hospitalized Due to COVID-19
af: Alireza FakhriRavari, et al.
Udgivet: (2024)

Chitosan-Based Nanocarriers for Delivery of Remdesivir
af: Viktoria Milkova, et al.
Udgivet: (2023)

Evidence for the Effectiveness of Remdesivir (GS-5734), a Nucleoside-Analog Antiviral Drug in the Inhibition of IK(M) or IK(DR) and in the Stimulation of IMEP
af: Wei-Ting Chang, et al.
Udgivet: (2020)

Model for predicting risk of developing drug-induced liver injury during remdesivir therapy: observational prospective open case-control study
af: Yu. V. Shevchuk, et al.
Udgivet: (2023)

Drug-induced Adverse Events and Prescribing Cascades in Older Adults: Pharmacy Stakeholder Survey
af: Scott Martin Vouri, et al.
Udgivet: (2017)

From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery
af: Karla de Castro Figueiredo Bordon, et al.
Udgivet: (2020)

Deaths and hospitalizations resulting from poisoning by prescription and over-the-counter drugs in Brazil
af: Fernanda Gross Duarte, et al.
Udgivet: (2021)

Prevalence and risk of potentially adverse drug interactions in the treatment of acute alcohol poisoning
af: Joyce Dalline Silva Andrade, et al.

The journey of remdesivir: from Ebola to COVID-19
af: Joe Pardo, et al.
Udgivet: (2020)

Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys
af: Lin Xu, et al.
Udgivet: (2021)

Safety of Remdesivir and Tocilizumab in COVID-19 Treatment
af: Alexandra A. Taube, et al.
Udgivet: (2020)

Remdesivir-Bringing Hope for COVID-19 Treatment
af: Naser F. Al-Tannak, et al.
Udgivet: (2020)

The use of Remdesivir in pregnant women with COVID-19
af: Gulbanu Shaimerdenova, et al.
Udgivet: (2023)

Quality assurance strategy of pharmacy compounded drugs
af: O. A. Zdoryk
Udgivet: (2019)